These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 35562557)

  • 1. Duchenne muscular dystrophy newborn screening: the first 50,000 newborns screened in Taiwan.
    Chien YH; Lee NC; Weng WC; Chen LC; Huang YH; Wu CS; Hwu WL
    Neurol Sci; 2022 Jul; 43(7):4563-4566. PubMed ID: 35562557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two years of newborn screening for Duchenne muscular dystrophy as a part of the statewide Early Check research program in North Carolina.
    Kucera KS; Boyea BL; Migliore B; Potter SN; Robles VR; Kutsa O; Cope H; Okoniewski KC; Wheeler A; Rehder CW; Smith EC; Peay HL
    Genet Med; 2024 Jan; 26(1):101009. PubMed ID: 37864479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Newborn screening and genomic analysis of duchenne muscular dystrophy in Henan, China.
    Jia C; Zhao D; Li Y; Gao Y; Zhang X; Li X; Lv S; Li R; Zhu X; Liu S
    Clin Chim Acta; 2023 Jan; 539():90-96. PubMed ID: 36516925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Newborn screening for Duchenne muscular dystrophy: A two-year pilot study.
    Tavakoli NP; Gruber D; Armstrong N; Chung WK; Maloney B; Park S; Wynn J; Koval-Burt C; Verdade L; Tegay DH; Cohen LL; Shapiro N; Kennedy A; Noritz G; Ciafaloni E; Weinberger B; Ellington M; Schleien C; Spinazzola R; Sood S; Brower A; Lloyd-Puryear M; Caggana M;
    Ann Clin Transl Neurol; 2023 Aug; 10(8):1383-1396. PubMed ID: 37350320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implementation of Hospital-Based Supplemental Duchenne Muscular Dystrophy Newborn Screening (sDMDNBS): A Pathway to Broadening Adoption.
    Parad RB; Sheldon Y; Bhattacharjee A
    Int J Neonatal Screen; 2021 Nov; 7(4):. PubMed ID: 34842620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence-based path to newborn screening for Duchenne muscular dystrophy.
    Mendell JR; Shilling C; Leslie ND; Flanigan KM; al-Dahhak R; Gastier-Foster J; Kneile K; Dunn DM; Duval B; Aoyagi A; Hamil C; Mahmoud M; Roush K; Bird L; Rankin C; Lilly H; Street N; Chandrasekar R; Weiss RB
    Ann Neurol; 2012 Mar; 71(3):304-13. PubMed ID: 22451200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Creatine kinase-MM concentration in dried blood spots from newborns and implications for newborn screening for Duchenne muscular dystrophy.
    Park S; Maloney B; Caggana M; Tavakoli NP
    Muscle Nerve; 2022 Jun; 65(6):652-658. PubMed ID: 35307847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identifying Non-Duchenne Muscular Dystrophy-Positive and False Negative Results in Prior Duchenne Muscular Dystrophy Newborn Screening Programs: A Review.
    Gatheridge MA; Kwon JM; Mendell JM; Scheuerbrandt G; Moat SJ; Eyskens F; Rockman-Greenberg C; Drousiotou A; Griggs RC
    JAMA Neurol; 2016 Jan; 73(1):111-6. PubMed ID: 26594870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Screening for Duchenne muscular dystrophy in newborns in the Ningxia region].
    Jing M; Wang Y; Jing XY; Mao XM
    Zhongguo Dang Dai Er Ke Za Zhi; 2024 Mar; 26(3):258-261. PubMed ID: 38557377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Newborn screening for Duchenne muscular dystrophy-early detection and diagnostic algorithm for female carriers of Duchenne muscular dystrophy.
    Gruber D; Lloyd-Puryear M; Armstrong N; Scavina M; Tavakoli NP; Brower AM; Caggana M; Chung WK
    Am J Med Genet C Semin Med Genet; 2022 Jun; 190(2):197-205. PubMed ID: 36152336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age-Related Blood Levels of Creatine Kinase-MM in Newborns and Patients with Duchenne Muscular Dystrophy: Considerations for the Development of Newborn Screening Algorithms.
    Potter SN; Migliore B; Carter J; Copeland VR; Smith EC; Peay HL; Kucera KS
    Int J Neonatal Screen; 2024 Jun; 10(2):. PubMed ID: 38920848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A pilot study of newborn screening for Duchenne muscular dystrophy in Guangzhou.
    Jia X; Jiang X; Huang Y
    Heliyon; 2022 Oct; 8(10):e11071. PubMed ID: 36281417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of a Blood Spot Creatine Kinase Skeletal Muscle Isoform Immunoassay for High-Throughput Newborn Screening of Duchenne Muscular Dystrophy.
    Moat SJ; Korpimäki T; Furu P; Hakala H; Polari H; Meriö L; Mäkinen P; Weeks I
    Clin Chem; 2017 Apr; 63(4):908-914. PubMed ID: 28209627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening for Duchenne muscular dystrophy in Germany, 1977-2011: A personal story.
    Scheuerbrandt G
    Muscle Nerve; 2018 Feb; 57(2):185-188. PubMed ID: 28981144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Duchenne Muscular Dystrophy Newborn Screening: Evaluation of a New GSP
    Timonen A; Lloyd-Puryear M; Hougaard DM; Meriö L; Mäkinen P; Laitala V; Pölönen T; Skogstrand K; Kennedy A; Airenne S; Polari H; Korpimäki T
    Int J Neonatal Screen; 2019 Sep; 5(3):27. PubMed ID: 33072986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Newborn bloodspot screening for Duchenne muscular dystrophy: 21 years experience in Wales (UK).
    Moat SJ; Bradley DM; Salmon R; Clarke A; Hartley L
    Eur J Hum Genet; 2013 Oct; 21(10):1049-53. PubMed ID: 23340516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Report of MDA muscle disease symposium on newborn screening for Duchenne muscular dystrophy.
    Mendell JR; Lloyd-Puryear M
    Muscle Nerve; 2013 Jul; 48(1):21-6. PubMed ID: 23716304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors influencing creatine kinase-MM concentrations in newborns and implications for newborn screening for Duchenne muscular dystrophy.
    Maloney B; Park S; Sowizral M; Brackett I; Moslehi R; Chung WK; Gruber D; Brower A; Lloyd-Puryear M; Caggana M; Tavakoli NP
    Clin Biochem; 2023 Aug; 118():110614. PubMed ID: 37479106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the GSP Creatine Kinase-MM Assay and Assessment of CK-MM Stability in Newborn, Patient, and Contrived Dried Blood Spots for Newborn Screening for Duchenne Muscular Dystrophy.
    Migliore BA; Zhou L; Duparc M; Robles VR; Rehder CW; Peay HL; Kucera KS
    Int J Neonatal Screen; 2022 Jan; 8(1):. PubMed ID: 35225934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exome Sequencing and Optical Genome Mapping in Molecularly Unsolved Cases of Duchenne Muscular Dystrophy: Identification of a Causative X-Chromosomal Inversion Disrupting the
    Erbe LS; Hoffjan S; Janßen S; Kneifel M; Krause K; Gerding WM; Döring K; Güttsches AK; Roos A; Buena Atienza E; Gross C; Lücke T; Nguyen HHP; Vorgerd M; Köhler C
    Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37834164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.